BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8538251)

  • 1. [The need of a registry of HLA-phenotyped platelet donors].
    Castro Izaguirre E; Muncunill Ribas J
    Med Clin (Barc); 1995 Nov; 105(18):696-9. PubMed ID: 8538251
    [No Abstract]   [Full Text] [Related]  

  • 2. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients.
    Duqesnoy RJ
    Prog Clin Biol Res; 1978; 28():229-43. PubMed ID: 88057
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of HLA antibody testing using ELISA vs the fluorescent bead method and retrospective review of data for recipients of packed RBCs and platelets from male HLA-immunized donors.
    Aung FM; Cano P; Fernandez-Vina M; Lichtiger B
    Am J Clin Pathol; 2011 Jan; 135(1):90-5. PubMed ID: 21173129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet crossmatch testing for donor selection.
    Slichter SJ
    Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors.
    Vox Sang; 2003 Jan; 84(1):73-88. PubMed ID: 12542737
    [No Abstract]   [Full Text] [Related]  

  • 8. [Practical usefulness of a donor registry with determined HLA class I antigens--current personal experience].
    Gronkowska A; Uhrynowska M; Gromadzka G; Zupańska B
    Acta Haematol Pol; 1993; 24(2):161-7. PubMed ID: 8372616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supportive haemotherapy in bone marrow transplantation.
    Mayr WR
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):455-8. PubMed ID: 2480289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Panels of phenotyped donors in the HLA system. Current applications].
    Puig L; Mazzara R
    Med Clin (Barc); 1987 Sep; 89(7):278-80. PubMed ID: 3316869
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet refractoriness--practical approaches and ongoing dilemmas in patient management.
    Stanworth SJ; Navarrete C; Estcourt L; Marsh J
    Br J Haematol; 2015 Nov; 171(3):297-305. PubMed ID: 26194869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the patient alloimmunized to platelets.
    Tomasulo PA; Doddridge D; Reynolds AW
    J Fla Med Assoc; 1984 Jun; 71(6):397-9. PubMed ID: 6544323
    [No Abstract]   [Full Text] [Related]  

  • 13. [Resuscitation necessitated by a transfusion reaction after HLA mismatched platelets substitution].
    Kuntz BM; Schöttler B; Brüster HT
    Beitr Infusionsther Transfusionsmed; 1994; 32():307-9. PubMed ID: 9480114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological principles of transfusion of blood platelet and granulocyte concentrates].
    Zupańska B
    Acta Haematol Pol; 1979 Oct; 10(4):327-32. PubMed ID: 539356
    [No Abstract]   [Full Text] [Related]  

  • 15. Finding platelets: Don't let the perfect be the enemy of the good.
    Brunker PAR; Pattanayak V; Mahowald GK
    Transfusion; 2021 Aug; 61(8):2223-2228. PubMed ID: 34365668
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological aspects of platelet transfusions.
    Murphy MF; Waters AH
    Br J Haematol; 1985 Jul; 60(3):409-14. PubMed ID: 4015986
    [No Abstract]   [Full Text] [Related]  

  • 17. How much residual plasma may cause TRALI?
    Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
    Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of patients with hematologic malignancies and aplastic anemia who are refractory to platelet transfusions.
    Sandler SG
    Haematologia (Budap); 1998; 29(1):1-11. PubMed ID: 9704252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable expression of w4 and w6 on platelets: possible relevance to platelet transfusion therapy of alloimmunized thrombocytopenic patients.
    Duquesnoy RJ; Testin J; Aster RH
    Transplant Proc; 1977 Dec; 9(4):1829-31. PubMed ID: 601844
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of HLA-C matching in histocompatible platelet transfusion therapy of alloimmunized thrombocytopenic patients.
    Duquesnoy RJ; Filip DJ; Tomasulo PA; Aster RH
    Transplant Proc; 1977 Dec; 9(4):1827-8. PubMed ID: 601843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.